Schizophrenia Research
Volume 41, Issue 3 , Pages 389-395 , 14 February 2000

Effects of age, medication, and illness duration on the N-acetyl aspartate signal of the anterior cingulate region in schizophrenia

  • Gabriele Ende

      Affiliations

    • NMR Research in Psychiatry, Central Institute of Mental Health, J5, 68159 Mannheim, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49-621-1703670; fax: +49-621-1703673
    • ,
  • Dieter F. Braus

      Affiliations

    • NMR Research in Psychiatry, Central Institute of Mental Health, J5, 68159 Mannheim, Germany
    • ,
  • Sigrid Walter

      Affiliations

    • NMR Research in Psychiatry, Central Institute of Mental Health, J5, 68159 Mannheim, Germany
    • ,
  • Wolfgang Weber-Fahr

      Affiliations

    • NMR Research in Psychiatry, Central Institute of Mental Health, J5, 68159 Mannheim, Germany
    • ,
  • Brian Soher

      Affiliations

    • DVA Medical Center, Department of Radiology, University of California, San Francisco, CA 94121, USA
    • ,
  • Andrew A. Maudsley

      Affiliations

    • DVA Medical Center, Department of Radiology, University of California, San Francisco, CA 94121, USA
    • ,
  • Fritz A. Henn

      Affiliations

    • NMR Research in Psychiatry, Central Institute of Mental Health, J5, 68159 Mannheim, Germany

Received 3 February 1999 ,Accepted 20 May 1999.

References 

  1. American Psychiatric Association Staff . Diagnostic and statistical manual of mental disorders DSM-III-R. Washington, DC: American Psychiatric Press Inc; 1987;
  2. Anderton BH. Changes in the ageing brain in health and disease. Phil. Trans. R. Soc. Lond. B. Biol. Sci. 1997;29:1781–1792
  3. Bartha R, Williamson PC, Drost DJ, Malla A, Carr TJ, Cortese L, et al. Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy. Arch. Gen. Psychiatry. 1997;54:959–965
  4. Bertolino A, Nawroz S, Mattay VS, Barnett AS, Duyn JH, Moonen CTW, et al. Regional specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am. J. Psychiatry. 1996;153:1554–1563
  5. Buchsbaum MS, Hazlett EA. Functional brain imaging and aging in schizophrenia. Schizophr. Res. 1997;27:129–141
  6. Christiansen P, Toft P, Larsson HB, Stubgaard M, Henriksen O. The concentration of N-acetyl aspartate, creatine+phosphocreatine, and choline in different parts of the brain in adulthood and senium. Magn. Reson. Imaging. 1993;11:799–806
  7. Deicken RF, Zhou L, Schuff N, Weiner MW. Proton magnetic resonance spectroscopy of the anterior cingulate region in schizophrenia. Schizophr. Res. 1997;27:65–71
  8. DeLisi LE, Tew W, Xie S, Hoff AL, Sakuma M, Kushner M, et al. A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients: preliminary findings. Biol. Psychiatry. 1995;38:349–360
  9. DeLisi LE, Sakuma M, Tew W, Kushner M, Hoff AL, Grimson R. Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Res. 1997;74:129–140
  10. Deutch AY, Duman RS. The effects of antipsychotic drugs on Fos protein expression in the prefrontal cortex: cellular localization and pharmacological characterization. Neuroscience. 1996;70:377–389
  11. Ende G, Laxer KD, Knowlton R, Schuff N, Matson GB, Weiner MW. Temporal lobe epilepsy: bilateral hippocampal metabolite changes revealed at proton MR spectroscopic imaging. Radiology. 1997;202:809–818
  12. Ende G, Braus DF, Kühnen , Henn FA. In: Proton MRSI in the Cingulate Gyrus of Schizophrenic Patients. Proceedings ISMRM, Vancouver. 1997;p. 1166
  13. Henderson G, Tomlinson BE, Gibson PH. Cell counts in human cerebral cortex in normal adults throughout life using image analysis computer. J. Neurol. 1980;21:530–539
  14. Jentsch JD, Redmond DE, Elsworth JD, Taylor JR, Youngren KD, Roth RH. Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine. Science. 1997;277:953–955
  15. Madsen AL, Keidling N, Karle A, Esbjerg S, Hemmingsen R. Neuroleptics in progressive structural brain abnormalities in psychiatric illness. Lancet. 1998;352:784–785
  16. Maudsley AA, Matson GB, Hugg JW, Weiner MW. Reduced phase encoding in spectroscopic imaging. Magn. Reson. Med. 1994;31:645–651
  17. Meltzer HY, Thompson PA, Lee MA, Ranjan R. Neuropsychologic deficits in schizophrenia: relation to social function and effect of antipsychotic drug treatment. Neuropsychopharmacology. 1996;14:27–33
  18. Michaelis T, Merboldt KD, Bruhn H, Hänicke W, Frahm J. Absolute concentration of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology. 1993;187:219–227
  19. O'Callaghan E, Buckley P, Redmond O, Stack J, Ennis JT, Larkin C, et al. Abnormalities of cerebral structure in schizophrenia on magnetic resonance imaging: interpretation in relation to the neurodevelopmental hypothesis. J. R. Soc. Med. 1992;85:227–231
  20. Pfefferbaum A, Mathalon DH, Sullivan EV, Rawles JM, Zipursky RB, Lim KO. A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood. Arch. Neurol. 1994;51:874–887
  21. Robertson GS, Fibiger HC. Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine. Neuroscience. 1992;46:315–328
  22. Robertson GS, Matsumura H, Fibiger HC. Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. J. Pharmacol. Exp. Ther. 1994;271:1058–1066
  23. Soher BJ, van Zijl PC, Duyn JH, Barker PB. Quantitative proton MR spectroscopic imaging of the human brain. Magn. Reson. Med. 1996;35:356–363
  24. Soher BJ, Young K, Govindaraju V, Maudsley AA. Automated spectral analysis III: application to in-vivo proton MR spectroscopy and spectroscopic imaging. Magn. Reson. Med. 1998;40:822–831
  25. Sullivan EV, Marsh L, Mathalon DH, Lim KO, Pfefferbaum A. Age-related decline in MRI volumes of temporal lobe gray matter but not hippocampus. Neurobiol. Aging. 1995;16:591–606
  26. Terry RD, DeTeresa R, Hansen LA. Neocortical cell counts in normal human adult aging. Ann. Neurol. 1987;21:530–539
  27. Weinberger DR, Lipska BK. Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground. Schizophr. Res. 1995;16:87–110
  28. Woods BT. Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism. Am. J. Psychiatry. 1998;155:1661–1670
  29. Young K, Govindaraju V, Soher BJ, Maudsley AA. Automated spectral analysis I: formation of a priori information by spectral simulation. Magn. Reson. Med. 1998;40:812–815
  30. Young K, Soher BJ, Maudsley AA. Automated Spectral Analysis II: Application of wavelet shrinkage for characterization of non-parameterized signals. Magn. Reson. Med. 1998;40:816–821

PII: S0920-9964(99)00089-4

Schizophrenia Research
Volume 41, Issue 3 , Pages 389-395 , 14 February 2000

Article Tools

* Image Usage & Resolution